Değer202020212022202320242025TTMYatırım faaliyetlerinden elde edilen nakit-159.44 M-632.37 M517 K76.71 M12.86 M-12.34 M-20.9 MFinansman faaliyetlerinden elde edilen nakit235.6 M725.28 M11.83 M4.55 M4.65 M-200.29 M-201.57 MSerbest nakit akışı1.46 M-26.72 M-65.99 M-1.95 M7.02 M-21.78 M-5.09 M
NeoGenomics, Inc. - Common Stock
NeoGenomics Laboratories, Inc., also known as NeoGenomics or Neo, is an American CLIA-certified clinical laboratory, pharma services and information services company that specializes in cancer genetics diagnostic testing. The company's testing services include cytogenetics, fluorescence in situ hybridization, flow cytometry, immunohistochemistry, anatomic pathology, and molecular genetics.
Headquartered in Fort Myers, FL, NeoGenomics maintains a network of testing facilities across the US, with laboratories in Florida, California, Tennessee, and Texas.